GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amyris Inc (AMRS) [hlAlert]

Rating:
Sell AMRS
up 91.17 %

Amyris Inc (AMRS) rated Sell by ThinkEquity

Posted on: Wednesday,  Aug 1, 2012  8:25 AM ET by ThinkEquity

ThinkEquity rated Sell Amyris Inc (NASDAQ: AMRS) on 08/01/2012, when the stock price was $3.25. Since
then, Amyris Inc has lost 47.69% as of 10/23/2015's recent price of $1.70.
If you would have followed this ThinkEquity's recommendation on AMRS, you would have gained 91.17% of your investment in 1178 days.

Amyris, Inc., formerly Amyris Biotechnologies, Inc. develops and provides renewable compounds for a variety of markets. As of September 30, 2010, the Company was building and applying its industrial synthetic biology platform to provide alternatives to petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The Company is focused on a molecule, farnesene, which forms the basis for a range of products varying from specialty chemical applications to transportation fuels, such as diesel. It genetically modifies micro organisms, primarily yeast, and uses them as living factories in established fermentation processes to convert plant-sourced sugars into thousands of molecules. The Company operates research and development laboratories in Emeryville, California, and has built an adjacent pilot facility that tests its yeast strains in 300 liter scale fermentors.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/1/2012 8:25 AM Sell
None
3.25
as of 12/31/2012
1 Week down  -11.82 %
1 Month down  -10.24 %
3 Months up  9.30 %
1 YTD up  4.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy